Farzan Nima Insider Trades

Insider Trading History

Track insider trading activity for Farzan Nima. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Keros Therapeutics
Keros Therapeutics KROS
Director
Holding Value $110k 10,500 shares
Last Trade
Jun 04, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$156k 10,500 shares
$14.82
$10.50
Keros Therapeutics
Keros Therapeutics KROS
Director
Holding Value $105k 10,000 shares
Last Trade
May 30, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$463k 10,000 shares
$46.31
$10.50
Kinnate Biopharma
Kinnate Biopharma KNTE
CHIEF EXECUTIVE OFFICER
Holding Value $0 0 shares
Last Trade
Apr 03, 2024 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$8.34M 3,146,241 shares
$2.65
$2.65
Keros Therapeutics
Keros Therapeutics KROS
Director
Holding Value $105k 10,000 shares
Last Trade
Jun 06, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$488k 10,000 shares
$48.79
$10.50
Kinnate Biopharma
Kinnate Biopharma KNTE
Chief Executive Officer
Holding Value $1.99M 750,000 shares
Last Trade
Feb 10, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$5.09M 750,000 shares
$6.78
$2.65
Kinnate Biopharma
Kinnate Biopharma KNTE
Chief Executive Officer
Holding Value $570k 215,000 shares
Last Trade
Feb 10, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$5.09M 750,000 shares
$6.78
$2.65
Keros Therapeutics
Keros Therapeutics KROS
Director
Holding Value $87.1k 8,293 shares
Last Trade
Jun 01, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$273k 8,293 shares
$32.95
$10.50
Kinnate Biopharma
Kinnate Biopharma KNTE
Chief Executive Officer
Holding Value $1.06M 400,000 shares
Last Trade
Feb 11, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.01M 400,000 shares
$10.03
$2.65
Keros Therapeutics
Keros Therapeutics KROS
Director
Holding Value $87.1k 8,293 shares
Last Trade
Jun 01, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$427k 8,293 shares
$51.48
$10.50
Kinnate Biopharma
Kinnate Biopharma KNTE
Chief Executive Officer
Holding Value $729k 275,000 shares
Last Trade
Feb 12, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$9.73M 275,000 shares
$35.38
$2.65
Kinnate Biopharma
Kinnate Biopharma KNTE
President And CEO
Holding Value $0 0 shares
Last Trade
Dec 02, 2020 Sale
No data
No data
$2.65
Keros Therapeutics
Keros Therapeutics KROS
Director
Holding Value $89.3k 8,500 shares
Last Trade
May 29, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$244k 8,500 shares
$28.74
$10.50
Kinnate Biopharma
Kinnate Biopharma KNTE
President And CEO
Holding Value $0 0 shares
Last Trade
Mar 23, 2020 Sale
No data
No data
$2.65

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up